Literature DB >> 19329438

The traffic of the NKG2D/Dap10 receptor complex during natural killer (NK) cell activation.

Pedro Roda-Navarro1, Hugh T Reyburn.   

Abstract

NKG2D is an important activating receptor for triggering the NK cell cytotoxic activity, although chronic engagement of specific ligands by NKG2D is also known to provoke decreased cell surface expression of the receptor and compromised NK cell function. We have studied the dynamics of surface NKG2D expression and how exposure to the specific ligand major histocompatibility complex class I chain-related molecule B (MICB) affects receptor traffic and fate. While in the NKL cell line and "resting" NK cells NKG2D was found principally at the cell surface, in activated primary NK cells an intracellular pool of receptor could also be found recycling to the plasma membrane. Exposure of NK cells to targets expressing MICB resulted in degradation of approximately 50% of total NKG2D protein and lysosomal degradation of the DAP10 adaptor molecule. Consistent with these observations, confocal microscopy experiments demonstrated that DAP10 trafficked to secretory lysosomes in both transfected NKL cells and in activated primary NK cells upon interaction with MICB-expressing target cells. Interestingly, polarization to the synapse of secretory lysosomes containing DAP10 was also observed. The implications of the intracellular traffic of the NKG2D/DAP10 receptor complex for NK cell activation are discussed. We propose that the rapid degradation of NKG2D/DAP10 observed coincident with recruitment of the receptor to the cytotoxic immune synapse may explain the loss of NKG2D receptor expression after chronic exposure to NKG2D ligands.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19329438      PMCID: PMC2713546          DOI: 10.1074/jbc.M808561200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

1.  An activating immunoreceptor complex formed by NKG2D and DAP10.

Authors:  J Wu; Y Song; A B Bakker; S Bauer; T Spies; L L Lanier; J H Phillips
Journal:  Science       Date:  1999-07-30       Impact factor: 47.728

2.  Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance.

Authors:  David E Oppenheim; Scott J Roberts; Sarah L Clarke; Renata Filler; Julie M Lewis; Robert E Tigelaar; Michael Girardi; Adrian C Hayday
Journal:  Nat Immunol       Date:  2005-08-14       Impact factor: 25.606

Review 3.  Immunobiology of human NKG2D and its ligands.

Authors:  S González; V Groh; T Spies
Journal:  Curr Top Microbiol Immunol       Date:  2006       Impact factor: 4.291

4.  NKG2D is a costimulatory receptor for human naive CD8+ T cells.

Authors:  Kerima Maasho; Jessica Opoku-Anane; Alina I Marusina; John E Coligan; Francisco Borrego
Journal:  J Immunol       Date:  2005-04-15       Impact factor: 5.422

5.  Altered NKG2D function in NK cells induced by chronic exposure to NKG2D ligand-expressing tumor cells.

Authors:  Jérôme D Coudert; Jacques Zimmer; Elena Tomasello; Marek Cebecauer; Marco Colonna; Eric Vivier; Werner Held
Journal:  Blood       Date:  2005-05-10       Impact factor: 22.113

6.  Release of MICB molecules by tumor cells: mechanism and soluble MICB in sera of cancer patients.

Authors:  Helmut Rainer Salih; Dennis Goehlsdorf; Alexander Steinle
Journal:  Hum Immunol       Date:  2006-03-29       Impact factor: 2.850

7.  Sorting of Fas ligand to secretory lysosomes is regulated by mono-ubiquitylation and phosphorylation.

Authors:  Elisabetta Zuccato; Emma J Blott; Oliver Holt; Sara Sigismund; Michael Shaw; Giovanna Bossi; Gillian M Griffiths
Journal:  J Cell Sci       Date:  2006-12-12       Impact factor: 5.285

8.  NKG2D-mediated signaling requires a DAP10-bound Grb2-Vav1 intermediate and phosphatidylinositol-3-kinase in human natural killer cells.

Authors:  Jadee L Upshaw; Laura N Arneson; Renee A Schoon; Christopher J Dick; Daniel D Billadeau; Paul J Leibson
Journal:  Nat Immunol       Date:  2006-04-02       Impact factor: 25.606

9.  Proteolytic release of soluble UL16-binding protein 2 from tumor cells.

Authors:  Inja Waldhauer; Alexander Steinle
Journal:  Cancer Res       Date:  2006-03-01       Impact factor: 12.701

10.  Transfer of NKG2D and MICB at the cytotoxic NK cell immune synapse correlates with a reduction in NK cell cytotoxic function.

Authors:  Pedro Roda-Navarro; Mar Vales-Gomez; Susan E Chisholm; Hugh T Reyburn
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-18       Impact factor: 11.205

View more
  20 in total

1.  NKG2D initiates caspase-mediated CD3zeta degradation and lymphocyte receptor impairments associated with human cancer and autoimmune disease.

Authors:  Nobuyoshi Hanaoka; Bana Jabri; Zhenpeng Dai; Cezary Ciszewski; Anne M Stevens; Cassian Yee; Hideki Nakakuma; Thomas Spies; Veronika Groh
Journal:  J Immunol       Date:  2010-10-06       Impact factor: 5.422

Review 2.  Mechanisms and functions for the duration of intercellular contacts made by lymphocytes.

Authors:  Daniel M Davis
Journal:  Nat Rev Immunol       Date:  2009-07-17       Impact factor: 53.106

3.  Acquisition of activation receptor ligand by trogocytosis renders NK cells hyporesponsive.

Authors:  Cathrine A Miner; Tusar K Giri; Claire E Meyer; Mark Shabsovich; Sandeep K Tripathy
Journal:  J Immunol       Date:  2015-01-12       Impact factor: 5.422

4.  Expression, signaling proficiency, and stimulatory function of the NKG2D lymphocyte receptor in human cancer cells.

Authors:  Andrea Caballero Benitez; Zhenpeng Dai; Henning H Mann; Rebecca S Reeves; Daciana H Margineantu; Ted A Gooley; Veronika Groh; Thomas Spies
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-14       Impact factor: 11.205

Review 5.  Endocytosis and intracellular trafficking of human natural killer cell receptors.

Authors:  Madhan Masilamani; Giovanna Peruzzi; Francisco Borrego; John E Coligan
Journal:  Traffic       Date:  2009-08-05       Impact factor: 6.215

6.  NK Cells Expressing a Chimeric Activating Receptor Eliminate MDSCs and Rescue Impaired CAR-T Cell Activity against Solid Tumors.

Authors:  Robin Parihar; Charlotte Rivas; Mai Huynh; Bilal Omer; Natalia Lapteva; Leonid S Metelitsa; Stephen M Gottschalk; Cliona M Rooney
Journal:  Cancer Immunol Res       Date:  2019-01-16       Impact factor: 11.151

7.  The roles and potential mechanisms of HCST in the prognosis and immunity of KIRC via comprehensive analysis.

Authors:  Wei Wang; Shuai Li; Junhao Lin; Xiaobin Guo; Yanyan Xie; Wei Li; Yanrong Hao; Xudong Jiang
Journal:  Am J Transl Res       Date:  2022-02-15       Impact factor: 4.060

8.  Human NKG2D-ligands: cell biology strategies to ensure immune recognition.

Authors:  Lola Fernández-Messina; Hugh T Reyburn; Mar Valés-Gómez
Journal:  Front Immunol       Date:  2012-09-25       Impact factor: 7.561

9.  Regulation and gene expression profiling of NKG2D positive human cytomegalovirus-primed CD4+ T-cells.

Authors:  Helle Jensen; Lasse Folkersen; Søren Skov
Journal:  PLoS One       Date:  2012-08-01       Impact factor: 3.240

10.  Immunohistochemical analysis of the natural killer cell cytotoxicity pathway in human abdominal aortic aneurysms.

Authors:  Irene Hinterseher; Charles M Schworer; John H Lillvis; Elizabeth Stahl; Robert Erdman; Zoran Gatalica; Gerard Tromp; Helena Kuivaniemi
Journal:  Int J Mol Sci       Date:  2015-05-18       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.